Suggest to invest in IT and Pharma: Anand Tandon

In a chat with ET Now, Anand Tandon, Independent Analyst, shares his views on the market outlook. Edited Excerpts:

ET Now: You sound a bit circumspect about the near-term for the market. Any pocket that you are overweight on with say maybe a six-month to a nine-month perspective if not a three-month perspective?

Anand Tandon: The longer term, if you assume that the earnings growth began to start coming through, then obviously all the cyclicals will start doing well, or at least will start showing that they are doing well. So rather than looking at FY16 earnings right now, you are already looking at FY17. I would think that from a diversification as well as portfolio protection point of view, you should be in things which are related to exports. IT and pharma continue to remain fairly good areas to be in my view.